IMAGE SCAN HOLDINGS
PLC
("Image
Scan" or the "Company")
Final Results for the Year
Ended 30 September 2024
Image Scan (AIM: IGE), the
specialist supplier of X-ray screening systems to the security and
industrial inspection markets, today announces final results for the year ended 30 September
2024.
HIGHLIGHTS
FINANCIAL HEADLINES
·
Order intake up to £6.6m (2023: £2.9m)
·
Sales £2.9m (2023: £3.0m)
·
Gross profit 53% (2023:48%)
·
Administrative expenses down to £1.3m (2023:
£1.4m)
·
Pre-tax profit £0.2m (2023: profit
£0.1m)
·
Year-end order book £4.47m (2023:
£0.65m)
·
Year-end cash balance £0.91m (2023:
£0.96m)
Image Scan's Chief Executive, Vince Deery,
commented:
This year's performance demonstrates
significant progress, driven by growing market confidence in our
solutions. Sales were consistent with the prior year, while gross
profit improved to 53%, and administrative expenses were further
reduced, highlighting the success of our cost control initiatives,
now in their third year.
Our pre-tax profit has doubled,
reflecting our disciplined operational approach and ability to
convert opportunity into sustained profitability. The year-end
order book, at £4.47m, is at an unprecedented high level, providing
excellent visibility into the coming year and a strong platform for
future growth.
The team's commitment has been vital
to this success, and I am immensely proud of their efforts. Looking
ahead, we remain focused on delivering value and reinforcing our
market position. As we continue to build on this positive momentum,
we are also exploring strategic opportunities to enhance our
capabilities and drive future growth.
For further information on the
Company, please visit: www.ish.co.uk and for further information on its products, please
visit: www.3dx-ray.com
-ENDS-
Image Scan Holdings plc
Tel: +44 (0) 1509 817400
Vincent Deery CEO
Sarah Atwell-King, CFO & Company
Secretary
Zeus - Nominated Advisor
and Corporate Broker
Tel: +44
(0)203 829 5000
Mike Coe/Sarah Mather (Investment
Banking)
ABOUT IMAGE SCAN HOLDINGS
PLC
About Image Scan Holdings plc
The core activity of the Group is the manufacture of portable
X-ray systems for security and counter terrorism applications. The
Group recently launched a cabinet X-ray machine and is replacing
its Axis range of checkpoint X-ray systems with new machines
developed with a partner. All these products are taken to market
across the world through a strong network of international
partners.
In
addition, over the last sixteen years, Image Scan has developed and
manufactured industrial X-ray inspection systems, the MDXi range.
The primary market for these systems is in automotive emissions
control where they are used for quality control inspection of
catalytic converters and diesel particulate
filters.
The visibility and reach of the Company's 3DX-Ray brand has
been further strengthened through a new LinkedIn profile focussed
on its EOD and counter-terrorism activities. This can be found at:
https://www.linkedin.com/company/3dx-ray/
For further information on the Company, please
visit: www.ish.co.uk -
and for further information on its products, please
visit: www.3dx-ray.com
CHAIRMAN'S STATEMENT
Overview
In 2024 Image Scan doubled profit,
secured a major defence contract win and generated a record order
book, with new products gaining traction, whilst sustaining cost
control activities.
Financial Summary
For the year ended 30 September 2024
(the "Year"), the Group generated revenues of £2.9m (2023: £3.0m),
and a profit before tax of £0.2m (2023: £0.1m). This performance
was the result of a sustained level of sales with good cost
control. Group cash balances have held steady at £0.91m (2023:
£0.96m).
The launch of new products has
played a significant factor in our improved performance and our
recent significant contract wins gives us confidence for
2025.
Environmental, Social and Governance
In the Year, Image Scan transitioned
to the new QCA code, taking the opportunity to review our processes
and policies. As part of this the directors have adopted a
code of practice based on the IOD recommendations. This
review process has considered the way we deliver our overarching
business objectives, ensuring that the needs of all our key
stakeholders are met. We are confident in the robust procedures we
have in place across the business and intend to continue building
on these in 2025.
Outlook
Our trading performance, aligning
with market expectations, reflects a commendable 115% increase in
profit before tax with revenue staying at a similar level to last
year. This accomplishment is a testament to the diligent efforts of
our restructured team and the positive impact of our product
development programme.
With a robust balance sheet and a
healthy cash position and a record order book, we stand on a strong
operational and financial foundation ready for growth. The recent
success with our updated product portfolio and the large contract
award instils confidence in our ability to achieve organic growth
and meet expectations for the current financial year.
While macroeconomic and geopolitical
uncertainties persist, we approach each opportunity with enthusiasm
and drive, engaging the collective talents of our team. The Board
of Directors remains confident in the Group's prospects in the
medium to long term. We are committed to capitalising on this
Year's performance and actively seeking strategic avenues for
growth in conjunction with our organic initiatives.
On behalf of the Board and the
dedicated team at Image Scan, I wish to thank our colleagues and
customers for their invaluable contributions throughout 2024. Their
commitment has been instrumental in our success which we outline
within this report.
Tim
Jackson
CHAIRMAN
CEO
REPORT
BUSINESS REVIEW
The introduction of the wider
product portfolio has as predicted broadened our scope of
opportunity and bolstered the Group's ability to compete in
international tenders.
The sales team's active
participation in trade shows and Counter Explosive Ordnance
(Counter EO) conventions and demonstrations has provided market
experts and thought leaders' exposure to the benefits of the
Group's latest product offerings and enhancements, which has
directly led to an improved financial performance and sales to over
30 different countries.
We have adeptly managed the
reduction in the industrial business supporting the catalyst market
(associated with the internal combustion engine) and its transition
of production to lower-cost countries. Our strategic measures have,
to date, successfully mitigated the impact of this transition on
our business demonstrating our resilience in the face of market
shifts.
Image Scan seeks to enable our
customers to be more effective by providing the best possible X-ray
imaging systems and ongoing support.
The Group's strategy focuses on the
organic growth of current activities by expansion of the product
range, and its target territories. The Group seeks to operate in
profitable, niche security segments for which it can offer
differentiated products that it offers to the market at good
margins.
In industrial screening, we will
continue to mitigate the reduction in the catalyst market related
to the internal combustion engine and its impact on the Group
revenue particularly as related to new equipment sales.
While the Group continues to focus
on expanding its product range to drive organic growth, it is also
actively pursuing strategic growth opportunities through
acquisitions.
The Group possesses extensive and
valuable expertise in establishing and maintaining market routes,
particularly in the field of security and Counter EO. It aims to
enhance these channels by incorporating new, in-house-developed
products or by identifying organisations that can provide
innovative technologies or products associated with the industry,
thereby enriching the Group's product portfolio. The process of
identifying and analysing organisations offering products or
services aligned with the Group has continued on from last year's
initial activity.
OUTLOOK
We expect the level of market
activity observed in the Year to be maintained, and with heightened
engagement at trade shows and conferences, we anticipate a strong
opportunity pipeline. Expanding our product range is not only a
safeguard for our market position but also provides access to
opportunities that were previously unavailable with our historic
product portfolio.
As previously announced in the
trading update, a major contract with a prominent defence
contractor valued at over £3m over a 36 month period has helped
provide a very strong opening order book which will enable a
constant level of underlying business and a foundation for the next
year.
We will concentrate on our core
expertise, specifically our portable X-ray products and associated
software. This strategic focus is aimed at sustaining and expanding
our market share, countering competition in this market. Our
approach involves extending our range into markets featuring higher
performance and higher value systems.
We will continue to manage the
reduction of the capital equipment sales into the catalytic
convertor manufacturers as this industry recognises the diminishing
prominence of internal combustion engines and the imperative shift
towards achieving net-zero emissions. We will actively pursue and
maintain the aftersales revenue that the Groups installed base of
this equipment provides.
Image Scan has successfully
navigated through the challenges posed by inflationary pressures
and has demonstrated excellent purchasing strategies and
organisational cost control measures.
With the refined organisational
structure and energetic team, revitalised product range, combined
with a strong opening order book we are well-positioned to sustain
the momentum of this year's achievements. Our goal is to enhance
the Group's profitability and leverage the advantages of the Group
listing to strategically advance the business. Our focus is on
executing deliberate actions that contribute to the growth of the
Group, moving beyond organic growth alone.
Vincent Deery
CHIEF EXECUTIVE OFFICER
CFO
REPORT
KEY
PERFORMANCE INDICATORS
|
2024
|
2023
|
2022
|
2021
|
2020
|
Order intake
|
£6.6m
|
£2.9m
|
£2.2m
|
£2.8m
|
£2.4m
|
Turnover
|
£2.9m
|
£3.0m
|
£2.0m
|
£2.9m
|
£3.5m
|
Gross margin
|
53%
|
48%
|
54%
|
53%
|
49%
|
Profit/(loss) before tax
|
£0.2m
|
£0.1m
|
(£0.4m)
|
£0.2m
|
£0.1m
|
Cash balance
|
£911k
|
£958k
|
£690k
|
£1,186k
|
£1,409k
|
Inventory Balance
|
£393k
|
£349k
|
£629k
|
£393k
|
£451k
|
FINANCIAL RESULTS
FY24 was a strong year for Image
Scan, delivering an increase in pre-tax profit of 115% up from £97k
to £208k, ahead of market expectation. This builds on the
good work initiated in 2023, with funds continuing to be invested
in delivering new products which is reflected in orders won in the
year while costs continue to be carefully managed. The
closing order book combined with improved working capital puts the
Group in a strong position to continue to deliver its strategy in
2025.
While sales were down slightly at
£2.9m against prior year of £3.0m, the gross margin percentage
increased due to careful purchasing and stock management and the
Group also benefited from a good dollar exchange rate. These
efforts have contributed to a gross margin of £1.5m (53%) against
£1.4m (48%) last year, evidencing the ongoing focus on driving
costs down as highlighted in last year's report.
The focus on delivering to customer
requirements has continued and the margin was achieved without
compromising on either the timeframes or the quality of product
delivered to our customers which is reflected in the low levels of
expenditure on warranty and is supported by the smooth
recertification of ISO9001:2015 at the end of the financial
year.
Cost control is also reflected in a
small decrease in administrative expenses of 3% in the year despite
inflationary pressures and builds on the 5% reduction delivered in
2023.
The Group continue to invest and
maintain in our product portfolio with a combined spend of £215k
(2023: £309k). Expenditure is down against last year because
product development was mainly delivered by the team without
external support. Due to the restrictions on available
schemes for our region, we were not able to access any grant
support in the Year and this, combined with the increasingly
restricted R&D tax credit regime, makes the ability of our
internal team crucial to delivering our product
strategy.
Our business model continues to be
to offer mainly cash neutral commercial terms, ideally in sterling
which allows us to make supplier payments in line with agreed
payment terms. We have set clear stock holding policies which
balances the cost of holding components against the need to meet
customer delivery deadlines. The net result of our cost
management is reflected in an increase in working capital as well
as our balance sheet. This means we will continue to investment in
our product portfolio as well as expanding our demonstration kits
in 2025 to showcase the full range of our product
portfolio.
All these measures lead to increase
in pre-tax profit by 115% from £97k to £208k and increasing our EPS
by almost 50% for our shareholders. Delivering this level of
improvement could not have been achieved without the commitment and
focus of all the team at Image Scan and I would add my thanks to
the whole team for their continuing efforts.
Sarah Atwell King
CHIEF FINANCIAL OFFICER
CONSOLIDATED STATEMENT OF COMPREHENSIVE
INCOME
For
the year ended 30 September 2024
|
Note
|
|
|
2024
£
|
2023
£
|
|
|
|
|
|
|
|
|
|
|
|
|
REVENUE
|
|
|
|
2,860,776
|
2,962,934
|
Cost of sales
|
|
|
|
(1,348,975)
|
(1,527,723)
|
|
|
|
|
|
|
Gross profit
|
|
|
|
1,511,801
|
1,435,211
|
|
|
|
|
|
|
Administrative expenses
|
|
|
|
(1,313,730)
|
(1,354,652)
|
Other operating income
|
|
|
|
3,474
|
14,934
|
|
|
|
|
|
|
OPERATING PROFIT
|
|
|
|
201,545
|
95,493
|
|
|
|
|
|
|
Finance income
|
|
|
|
10,736
|
6,639
|
Interest payable and similar
charges
|
|
|
|
(4,514)
|
(5,555)
|
|
|
|
|
|
|
PROFIT BEFORE TAXATION
|
|
|
|
207,767
|
96,577
|
|
|
|
|
|
|
Taxation
|
|
|
|
(756)
|
27,362
|
|
|
|
|
|
|
PROFIT AND TOTAL COMPREHENSIVE INCOME FOR THE YEAR FROM
CONTINUING OPERATIONS ATTRIBUTABLE TO THE EQUITY OWNERS OF THE
PARENT COMPANY
|
|
207,011
|
123,939
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pence
|
Pence
|
Earnings per share
|
2
|
|
|
|
|
Basic
|
|
|
|
0.15
|
0.09
|
Diluted
|
|
|
|
0.15
|
0.09
|
|
|
|
|
|
|
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
As
at 30 September 2024
|
|
|
|
2024
£
|
2023
£
|
NON-CURRENT ASSETS
|
|
|
|
|
|
Intangible assets
|
|
|
|
333,249
|
320,957
|
Property, plant and
equipment
|
|
|
|
-
|
6,599
|
Right of use asset
|
|
|
|
143,873
|
153,678
|
|
|
|
|
|
|
|
|
|
|
477,122
|
481,234
|
|
|
|
|
|
|
CURRENT ASSETS
|
|
|
|
|
|
Inventories
|
|
|
|
392,643
|
348,753
|
Trade and other
receivables
|
|
|
|
910,775
|
633,870
|
Cash and cash equivalents
|
|
|
|
911,468
|
958,465
|
|
|
|
|
|
|
|
|
|
|
2,214,886
|
1,941,088
|
|
|
|
|
|
|
TOTAL ASSETS
|
|
|
|
2,692,008
|
2,422,322
|
|
|
|
|
|
|
CURRENT LIABILITIES
|
|
|
|
|
|
Trade and other payables
|
|
|
|
792,167
|
712,455
|
Lease liability
|
|
|
|
53,158
|
37,625
|
Warranty provision
|
|
|
|
25,473
|
33,858
|
|
|
|
|
|
|
|
|
|
|
870,798
|
783,938
|
|
|
|
|
|
|
NON-CURRENT LIABILITIES
|
|
|
|
|
|
Lease liability
|
|
|
|
102,498
|
126,683
|
|
|
|
|
|
|
|
|
|
|
102,498
|
126,683
|
|
|
|
|
|
|
|
|
|
|
|
|
NET
ASSETS
|
|
|
|
1,718,712
|
1,511,701
|
|
|
|
|
|
|
EQUITY
|
|
|
|
|
|
Share capital
|
|
|
|
1,368,546
|
1,368,546
|
Share premium account
|
|
|
|
8,332,910
|
8,332,910
|
Profit and loss account
|
|
|
|
(7,982,744)
|
(8,189,755)
|
|
|
|
|
|
|
TOTAL EQUITY ATTRIBUTABLE TO SHAREHOLDERS
|
|
1,718,712
|
1,511,701
|
|
|
|
|
|
|
STATEMENT OF CHANGES IN EQUITY
For
the year ended 30 September 2024
|
Share capital
£
|
Share premium
£
|
Profit and loss account
£
|
Total
£
|
As at 1 October 2022
|
|
1,368,546
|
8,332,910
|
(8,313,694)
|
1,387,762
|
|
|
|
|
|
|
Profit for the year and total
comprehensive income for the year
|
|
-
|
-
|
123,939
|
123,939
|
|
|
|
|
|
|
As at 30 September 2023
|
|
1,368,546
|
8,332,910
|
(8,189,755)
|
1,511,701
|
|
|
|
|
|
|
Profit for the year and total
comprehensive income for the year
|
|
-
|
-
|
207,011
|
207,011
|
|
|
|
|
|
|
As
at 30 September 2024
|
|
1,368,546
|
8,332,910
|
(7,982,744)
|
1,718,712
|
|
|
|
|
|
|
CONSOLIDATED CASH FLOW STATEMENT
Year ended 30 September 2024
|
|
|
2024
£
|
2023
£
|
Cash flows from operating activities
|
|
|
|
|
Operating profit
|
|
|
201,545
|
95,493
|
|
|
|
|
|
Adjustments for:
|
|
|
|
|
Amortisation of intangible
assets
|
|
|
62,350
|
60,887
|
Depreciation
|
|
|
7,199
|
6,960
|
Amortisation of right of use
asset
|
|
|
40,524
|
39,375
|
Research and development expenditure
credit
|
|
|
(3,474)
|
-
|
(Decrease) in impairment of
inventories
|
|
|
(9,280)
|
(54,349)
|
(Increase)/decrease in
inventories
|
|
|
(34,610)
|
334,499
|
(Increase) in trade and other
receivables
|
|
|
(300,627)
|
(40,485)
|
Increase/(decrease) in trade and
other payables
|
|
|
79,712
|
(81,004)
|
(Decrease) in warranty
provisions
|
|
|
(8,385)
|
(4,072)
|
|
|
|
|
|
Cash generated from operating activities
|
|
|
34,954
|
357,304
|
Corporation tax received
|
|
|
26,440
|
72,269
|
|
|
|
|
|
|
|
61,394
|
429,573
|
|
|
|
|
|
Cash flows from investing activities
|
|
|
|
|
Interest received
|
|
|
10,736
|
6,639
|
Purchase of intangibles
|
|
|
(74,642)
|
(124,290)
|
Purchase of property, plant and
equipment
|
|
|
(600)
|
-
|
|
|
|
|
|
Net
cash used in investing activities
|
|
|
(64,506)
|
(117,651)
|
|
|
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
Lease payments (capital and
interest)
|
|
|
(43,885)
|
(43,000)
|
Proceeds from issue of share
capital
|
|
|
-
|
-
|
|
|
|
|
|
Net
cash used in financing activities
|
|
|
(43,885)
|
(43,000)
|
|
|
|
|
|
Net
(DECREASE)/INCREASE in cash and cash equivalents
|
(46,997)
|
268,922
|
Cash and cash equivalents at
beginning of year
|
|
|
958,465
|
689,543
|
|
|
|
|
|
Cash and cash equivalents at end of year
|
|
|
911,468
|
958,465
|
|
|
|
|
|
Notes to this statement
1. Basis of
preparation
While the financial information
included in this annual financial results announcement has been
prepared in accordance with the recognition and measurement
principles of UK adopted international accounting standards, this
announcement does not contain sufficient information to comply
therewith.
The financial information set out
above does not constitute the Group's statutory accounts for the
years ended 30 September 2024 or 30 September 2023 but is derived
from those accounts. Statutory accounts for 2023 have been
delivered to the Registrar of Companies, and those for 2024 will be
delivered following the Company's Annual General Meeting. The
auditors have reported on those accounts; their reports were
unqualified and did not contain statements under Section 498 of the
Companies Act 2006.
2. Earnings per
share
The diluted earnings per share is
calculated by adjusting the weighted average number of ordinary
shares in issue on the assumption of conversion of dilutive
potential ordinary shares. The Company's dilutive potential
ordinary shares are shares issued under the Company's Enterprise
Management Incentive ('EMI') scheme and options issued under the
Company's Unapproved scheme. Where the Company is reporting losses,
the impact of share options is considered anti-dilutive.
Where the Company is reporting profits, share options could
potentially dilute basic earnings per share in the future but are
only included in the calculation of diluted earnings per share when
the exercise price of the share options is below the average share
price in the year.
|
|
|
|
2024
£
|
2023
£
|
|
|
|
|
|
|
Profit for the year
|
|
|
|
207,011
|
123,939
|
|
|
|
|
|
|
Weighted average number of ordinary
shares in issue
|
|
|
136,854,577
|
136,854,577
|
Number of diluted shares
|
|
|
136,854,577
|
136,854,577
|
|
|
|
|
|
|
Basic profit per share
|
|
|
|
0.15p
|
0.09p
|
Diluted profit per share
|
|
|
|
0.15p
|
0.09p
|